Drawing for Serial No. 79115004

USPTO serial 79115004

Serial No. 79115004

Reviewed by CopyMark Law Group

Reg. 4385918Status 404
Filing date
Status date
Registration date
Aug 20, 2013
Examiner
BUSH, KAREN K
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79115004?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Biological and chemical substances used in industry and for scientific and research purposes, namely, diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents for research and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, synthesis, amplification, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of nucleic acid assays and chemical reagents for research, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromoleculesSECTION 71 - CANCELLED—
005Pharmaceutical and veterinary preparations, namely, biological substances and chemicals used for medical diagnostic purposes, namely, reagents and solvents, in particular for sample preparation, modification and manipulation of cells as well as for the performance of a synthesis, amplification, labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of protein assays and chemical reagents for medical scientific and medical research purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; in-vitro diagnostic preparations for medical purposes; sanitary preparations for medical purposesSECTION 71 - CANCELLED—
009Scientific apparatus and instruments for laboratory use, in particular for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances; scientific apparatus and instruments for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macromolecules and biologically active substances, spectrophotometers for measuring relative DNA; RNA and protein; computer hardware; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, for electrophoretic apparatuses, homogenizers, spectrophotometers and laboratory robots; computer software for creating experimental profiles and providing experimental reports based on sample preparation, modification and manipulation of cells as well as on synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; computer software for creating reports of apparatus performance verification; computer software for analyzing, displaying and visualizing experimental data and biological data, namely, PCR data, Real-Time-PCR data, and electrophoresis dataSECTION 71 - CANCELLED—
010Medical apparatus and implements, namely, apparatus and implements for the conducting and evaluation of clinical diagnostic examinations for medical purposesSECTION 71 - CANCELLED—
035Data processing servicesSECTION 71 - CANCELLED—
041Teaching services in the field of medical diagnosisSECTION 71 - CANCELLED—
042Scientific and technological services and research services and scientific consultancy services in the field of scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis; development of computer hardware and software for the operation and maintenance of scientific apparatus, instruments and equipment; development of computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; development of computer software for analyzing, displaying and visualizing experimental data and biological dataSECTION 71 - CANCELLED—
044Medical consultations; consulting services in the field of health; medical services; health care services; medical clinics; medical care servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 11, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 11, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Jan 22, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 23, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 23, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 27, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Aug 20, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 12, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 12, 2016CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 13, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 14, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 22, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 22, 2013FIMPFINAL DISPOSITION PROCESSED—
Nov 20, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 20, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 2013GPNXNOTIFICATION PROCESSED BY IB—
Jun 4, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 15, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 15, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 28, 2013PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 16, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 16, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 16, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Apr 16, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 16, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 16, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 8, 2013ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 17, 2013PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 7, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 7, 2013ALIEASSIGNED TO LIE—
Feb 25, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 11, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 6, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 6, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2012RFNTREFUSAL PROCESSED BY IB—
Aug 11, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 9, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 9, 2012RFRRREFUSAL PROCESSED BY MPU—
Aug 9, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 8, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2012DOCKASSIGNED TO EXAMINER—
Aug 7, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 6, 2012LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 2, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance